EFFICACY AND OUTCOMES OF A NON-PHARMACOLOGICAL INTERVENTION FOR NAS

October 18, 2018

The Study

SVS is being evaluated in a major NIH funded clinical study with infants exposed to drugs in the womb before birth.  Study enrollment is targeting 230 newborns with study completion in July 2021.

This on-going, multi-year study is examining the potential of SVS as a complementary non-pharmacological intervention for treating drug withdrawal in newborns exposed to opioids in utero. This independent study will measure improvements in symptoms and assess cognitive and behavioral outcomes of infants in the study at 1 month, 6 months and 12 months of age.

Read about the study >


Stay In Touch